Effects of cis-9,trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men
Open Access
- 1 August 2004
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 80 (2), 279-283
- https://doi.org/10.1093/ajcn/80.2.279
Abstract
Background: We recently showed that trans-10,cis-12 (t10,c12) conjugated linoleic acid (CLA) causes insulin resistance in obese men. However, metabolic effects of the c9,t11 CLA isomer are still unknown in obese men. Because c9,t11 CLA is the predominant CLA isomer in foods and is included in dietary weight-loss products, it is important to conduct randomized controlled studies that use c9,t11 CLA preparations. Objective: We investigated the effects of c9,t11 CLA supplementation on insulin sensitivity, body composition, and lipid peroxidation in a group at high risk for cardiovascular disease. Design: In a randomized, double-blind, placebo-controlled study, 25 abdominally obese men received 3 g c9,t11 CLA/d or placebo (olive oil). Before and after 3 mo of supplementation, we assessed insulin sensitivity (hyperinsulinemic euglycemic clamp), lipid metabolism, body composition, and urinary 8-iso-prostaglandin F2α (a major F2-isoprostane) and 15-keto-dihydro-prostaglandin F2α, markers of in vivo oxidative stress and inflammation, respectively. Results: All subjects completed the study. Compared with placebo, c9,t11 CLA decreased insulin sensitivity by 15% (P < 0.05) and increased 8-iso-prostaglandin F2α and 15-keto-dihydro-prostaglandin F2α excretion by 50% (P < 0.01) and 15% (P < 0.05), respectively. The decreased insulin sensitivity was independent of changes in serum lipids, glycemia, body mass index, and body fat but was abolished after adjustment for changes in 8-iso-prostaglandin F2α concentrations. There were no differences between groups in body composition. Conclusions: A CLA preparation containing the purified c9,t11 CLA isomer increased insulin resistance and lipid peroxidation compared with placebo in obese men. Because c9,t11 CLA occurs in commercial supplements as well as in the diet, the present results should be confirmed in larger studies that also include women.Keywords
This publication has 30 references indexed in Scilit:
- Supplementation With Conjugated Linoleic Acid Causes Isomer-Dependent Oxidative Stress and Elevated C-Reactive ProteinCirculation, 2002
- Dietary trans-10,cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouseJournal of Lipid Research, 2002
- The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjectsBritish Journal of Nutrition, 2002
- DIETARY CONJUGATED LINOLEIC ACID IN HEALTH: Physiological Effects and Mechanisms of ActionAnnual Review of Nutrition, 2002
- Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trialInternational Journal of Obesity, 2001
- Measurement of F2-isoprostanes as an index of oxidative stress in vivoFree Radical Biology & Medicine, 2000
- Oxidative Stress Disrupts Insulin-induced Cellular Redistribution of Insulin Receptor Substrate-1 and Phosphatidylinositol 3-Kinase in 3T3-L1 AdipocytesJournal of Biological Chemistry, 1999
- Dietary sources of conjugated dienoic isomers of linoleic acid, a newly recognized class of anticarcinogensJournal of Food Composition and Analysis, 1992
- Obesity and insulin resistance in humans: A dose-response studyMetabolism, 1990
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955